Detection of Glycosylated Markers From Cancer Stem Cells With ColoSTEM Dx Kit for Earlier Prediction of Colon Cancer Aggressiveness.

Blondy, Sabrina; Durand, Stéphanie; Lacroix, Aurélie; Christou, Niki; Bouchaud, Charline; Peyny, Maud; Battu, Serge; Chauvanel, Alain; Carré, Vincent; Jauberteau, Marie-Odile; Lalloué, Fabrice; Mathonnet, Muriel

Blondy, Sabrina; Durand, Stéphanie; Lacroix, Aurélie; Christou, Niki; Bouchaud, Charline; Peyny, Maud; Battu, Serge; Chauvanel, Alain; Carré, Vincent; Jauberteau, Marie-Odile; Lalloué, Fabrice; Mathonnet, Muriel.

Afiliação

Blondy S; Carcidiag Biotechnologies company, Guéret, France.
Durand S; INSERM U1308 - CAPTuR "Control of cell activation, Tumor progression and Therapeutic resistance", Faculty of Medicine, University of Limoges, Limoges, France.
Lacroix A; INSERM U1308 - CAPTuR "Control of cell activation, Tumor progression and Therapeutic resistance", Faculty of Medicine, University of Limoges, Limoges, France.
Christou N; INSERM U1308 - CAPTuR "Control of cell activation, Tumor progression and Therapeutic resistance", Faculty of Medicine, University of Limoges, Limoges, France.
Bouchaud C; Department of Digestive Surgery, Dupuytren University Hospital, Limoges, France.
Peyny M; Carcidiag Biotechnologies company, Guéret, France.
Battu S; Carcidiag Biotechnologies company, Guéret, France.
Chauvanel A; INSERM U1308 - CAPTuR "Control of cell activation, Tumor progression and Therapeutic resistance", Faculty of Medicine, University of Limoges, Limoges, France.
Carré V; Laboratory of Analytical Chemistry, Faculty of Pharmacy, Limoges, France.
Jauberteau MO; INSERM U1308 - CAPTuR "Control of cell activation, Tumor progression and Therapeutic resistance", Faculty of Medicine, University of Limoges, Limoges, France.
Lalloué F; Department of Pathology, Dupuytren University Hospital, Limoges, France.
Mathonnet M; Carcidiag Biotechnologies company, Guéret, France.

Front Oncol ; 12: 918702, 2022.

Article em En | MEDLINE | ID: mdl-35936672

Palavras-chave

cancer stem cells; colorectal carcinoma; early stage; glycosylated biomarkers; prognosis value; tumor aggressiveness

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google